Kenya starts trials of new drug for treatment of cryptococcal meningitis
by Oscar Nkala from Outbreak News Today on (#3SHMQ)
Scientists at the Kenya Medical Research Institute (Kemri) have started clinical trials of an oral drug that is deemed to be less toxic to the kidneys during the treatment of cryptococcus meningitis. The research project seeks to find out if the test drug, Fluconazole, can replace Amphotericin B, an intravenous drug presently used as a ["]
The post Kenya starts trials of new drug for treatment of cryptococcal meningitis appeared first on Outbreak News Today.